Table 3.
Mass (Da) | Breast |
Ovarian |
Prostate |
|
---|---|---|---|---|
Δ (%) | Δ B (%) | Δ C (%) | Δ (%) | |
1485.527* | 109.67 | 71.27 | 106.06 | −44.71 |
1486.533 | 112.88 | 73.64 | 110.48 | −46.04 |
1487.540 | 121.13 | 71.31 | 105.07 | −45.15 |
1809.629 * | −27.95 | −22.66 | −38.54 | −44.18 |
1810.632 | −28.48 | −22.57 | −38.69 | −44.48 |
1811.639 | −30.04 | −23.15 | −39.20 | −44.20 |
1812.648 | −32.73 | −23.12 | −40.35 | −42.07 |
Those marked with asterisks represent known glycans. Δ >0 means upregulated in cancer and is roughly the percentage difference on the raw scale. Δ B and Δ C are the differences from borderline tumor patients and cancer patients, respectively, to normal subjects. Horizontal lines separate presumed isotope groupings. See Section 3.